Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
The stocks loncar picked for the index are general good but highly risky, there are a few which I would not touch it, I would be careful. If you like this immunooncology space, you can play it with big boys in the space such as BMY/ mrk/ AZN, small ones such as Juno/kite.
Comments
It is also very expensive.